Perdagangan Novavax NVAX

Jual
 Beli

Novavax diagram langsung

5m 15m 30m 1h 4h 1d 1w

Dasar-dasar Instrumen

Weekly Search
Weekly
Daily
Tanggal Tutup Ubah Ubah (%) Buka Tinggi Rendah

Novavax news

2021 Mei 11, 13:20

US pre-market: selling unabated

2021 Mei 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 Mei 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Berita Terkini

Tampilkan lebih banyak
Liam James 2025 Aug 22, 15:20

Market Review & Investment Insights: August 2025

Noah Lee 2025 Aug 22, 15:20

Trump Threatens to Fire Fed Governor Lisa Cook Amid Mortgage Fraud Allegations

Liam James 2025 Aug 22, 15:20

Wall Street Reacts: Powell Hints at September Rate Cut, But Cautiously

Liam James 2025 Aug 22, 14:20

Dollar Bullish Sentiment Rises Ahead of Powell Speech, Forex Options Show

Ava Grace 2025 Aug 22, 12:20

Syria to Revalue Currency: Removing Zeros in Bid to Restore Confidence

Noah Lee 2025 Aug 22, 10:20

India, Russia Expand Trade Amid US Tariff Pressure

Ava Grace 2025 Aug 22, 08:20

Trump Administration Eyes Repurposing Chip Act Funds for Critical Minerals

Emma Rose 2025 Aug 22, 08:20

Powell's Jackson Hole Speech: Shaping the Fed's Future Amidst Economic Uncertainty

Info

Spread

0.05

Spread (%)

0.6394 %

Leverage

1:10

Bunga Overnight Beli

-0.0597 %

Bunga Overnight Jual

-0.0292 %

Mata Uang

USD

Jam Trading

Pasar tutup

Senin

13:31 - 19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Kamis

13:31-19:59

Jumat

13:31-19:59

Analisis dan Statistik

Buka

---

Sebelumnya Tutup

---

52 Minggu Tigg/Rdh

--- – ---

Kapitalisasi Pasar

1239279872

Saham yang Beredar

162422000

Tanggal Penghasilan (Berikutnya)

2019-05-10

Hasil Div

2019-05-10

Tanggal Non-Dividen

Proyeksi tingkat dividen tahunan

0

Proyeksi hasil dividen tahunan

0

EPS

2.22

Pelajari lebih lanjut tentang instrumen ini

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Instrumen Terkait

Aset
Jual
Beli
Ubah (%)

Lakukan Trading

Lakukan Trading

Lakukan Trading

Lakukan Trading
view_all_instruments

latest_education_articles

Tampilkan lebih banyak
Trustpilot